F13A1
This gene encodes the coagulation factor XIII A subunit. Coagulation factor XIII is the last zymogen to become activated in the blood coagulation cascade. Plasma factor XIII is a heterotetramer composed of 2 A subunits and 2 B subunits. The A subunits have catalytic function, and the B subunits do not have enzymatic activity and may serve as plasma carrier molecules. Platelet factor XIII is comprised only of 2 A subunits, which are identical to those of plasma origin. Upon cleavage of the activation peptide by thrombin and in the presence of calcium ion, the plasma factor XIII dissociates its B subunits and yields the same active enzyme, factor XIIIa, as platelet factor XIII. This enzyme acts as a transglutaminase to catalyze the formation of gamma-glutamyl-epsilon-lysine crosslinking between fibrin molecules, thus stabilizing the fibrin clot. It also crosslinks alpha-2-plasmin inhibitor, or fibronectin, to the alpha chains of fibrin. Factor XIII deficiency is classified into two categories: type I deficiency, characterized by the lack of both the A and B subunits; and type II deficiency, characterized by the lack of the A subunit alone. These defects can result in a lifelong bleeding tendency, defective wound healing, and habitual abortion. [provided by RefSeq, Jul 2008]
Full Name
Coagulation Factor XIII A Chain
Research Area
Factor XIII is activated by thrombin and calcium ion to a transglutaminase that catalyzes the formation of gamma-glutamyl-epsilon-lysine cross-links between fibrin chains, thus stabilizing the fibrin clot. Also cross-link alpha-2-plasmin inhibitor, or fibronectin, to the alpha chains of fibrin.
Biological Process
Blood coagulation Source: ProtInc
Blood coagulation, fibrin clot formation Source: UniProtKB
Peptide cross-linking Source: UniProtKB
Blood coagulation, fibrin clot formation Source: UniProtKB
Peptide cross-linking Source: UniProtKB
Cellular Location
Secreted; Cytoplasm. Secreted into the blood plasma. Cytoplasmic in most tissues, but also secreted in the blood plasma.
Involvement in disease
Factor XIII subunit A deficiency (FA13AD):
An autosomal recessive hematologic disorder characterized by a life-long bleeding tendency, impaired wound healing and spontaneous abortion in affected women.
An autosomal recessive hematologic disorder characterized by a life-long bleeding tendency, impaired wound healing and spontaneous abortion in affected women.
PTM
The activation peptide is released by thrombin.
View more
Anti-F13A1 antibodies
+ Filters

Target: F13A1
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: CB49A
Application*: WB, P, F
Target: F13A1
Host: Mouse
Antibody Isotype: IgG
Specificity: Human
Clone: M1
Application*: E, PLA
Target: F13A1
Host: Mouse
Antibody Isotype: IgG2b, κ
Specificity: Human
Clone: F2148
Application*: IH
Target: F13A1
Host: Mouse
Antibody Isotype: IgG2b, κ
Specificity: Human
Clone: CBXF-2287
Application*: WB, E, F, IF, IH
Target: F13A1
Host: Mouse
Antibody Isotype: IgG1, κ
Specificity: Human, Mouse, Rat
Clone: CBXF-2286
Application*: WB, IP, IF, E
Target: F13A1
Host: Mouse
Antibody Isotype: IgG2b, κ
Specificity: Human, Mouse, Rat
Clone: F1655
Application*: WB, IP, IF, P, E
Target: F13A1
Host: Mouse
Antibody Isotype: IgG2b
Specificity: Human, Mouse, Rat
Clone: CBXF-0147
Application*: WB, IH
Target: F13A1
Host: Rabbit
Antibody Isotype: IgG
Specificity: Human
Clone: CBXF-1073
Application*: WB, IH
Target: F13A1
Specificity: Human
Target: F13A1
Host: Mouse
Antibody Isotype: IgG2a
Specificity: Human, Mouse, Rat
Clone: 2B2
Application*: WB, IH
Target: F13A1
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: CBXF-3769
Application*: WB, P, F
Target: F13A1
Host: Mouse
Antibody Isotype: IgG2a
Specificity: Human
Clone: CBXF-3551
Application*: F, WB, P, IF
Target: F13A1
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: CBXF-0146
Application*: WB, E
Target: F13A1
Host: Rabbit
Antibody Isotype: IgG
Specificity: Human
Clone: EP3372
Application*: WB, IH, IF, F
More Infomation
Hot products 
For Research Use Only. Not For Clinical Use.
(P): Predicted
* Abbreviations
- AActivation
- AGAgonist
- APApoptosis
- BBlocking
- BABioassay
- BIBioimaging
- CImmunohistochemistry-Frozen Sections
- CIChromatin Immunoprecipitation
- CTCytotoxicity
- CSCostimulation
- DDepletion
- DBDot Blot
- EELISA
- ECELISA(Cap)
- EDELISA(Det)
- ESELISpot
- EMElectron Microscopy
- FFlow Cytometry
- FNFunction Assay
- GSGel Supershift
- IInhibition
- IAEnzyme Immunoassay
- ICImmunocytochemistry
- IDImmunodiffusion
- IEImmunoelectrophoresis
- IFImmunofluorescence
- IHImmunohistochemistry
- IMImmunomicroscopy
- IOImmunoassay
- IPImmunoprecipitation
- ISIntracellular Staining for Flow Cytometry
- LALuminex Assay
- LFLateral Flow Immunoassay
- MMicroarray
- MCMass Cytometry/CyTOF
- MDMeDIP
- MSElectrophoretic Mobility Shift Assay
- NNeutralization
- PImmunohistologyp-Paraffin Sections
- PAPeptide Array
- PEPeptide ELISA
- PLProximity Ligation Assay
- RRadioimmunoassay
- SStimulation
- SESandwich ELISA
- SHIn situ hybridization
- TCTissue Culture
- WBWestern Blot

Online Inquiry